Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
A novel microrna signature with clinical significance in multiple myeloma
A. Papanota; P. Artemaki; P. Karousi; C. Liacos; M. Gavriatopoulou; E. Kastritis; C. Kontos; M. Dimopoulos; A. Scorilas; E. Terpos;
Hematol Transfus Cell Ther. 2020;42 Supl 1:23-4
Peripheral blood immune profiling of multiple myeloma patients at diagnosis: correlations with circulating plasma cells
K. Papadimitriou; I. Ntanasis-Stathopoulos; N. Tsakirakis; M. Gavriatopoulou; I. Kostopoulos; E. Kastritis; N. Orologas-Stavrou; M. Dimopoulos; O. Tsitsilonis; E. Terpos;
Hematol Transfus Cell Ther. 2020;42 Supl 1:24
ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS
M.E.Z. Capra; M. Beksac; P.G. Richardson; A. Unal; P. Corradini; S. Delimpasi; Z. Gulbas; G. Mikala; A. Neylon; A. Symeonidis; S. Bringhen; P. Moreau; H.V. Velde; F. Campana; S.L. Guennec; I. Spicka;
Hematol Transfus Cell Ther. 2020;42 Supl 2:263-4